Verrill's patent attorneys specialize in assisting biotech and life science clients at every level from university research, to startups, to mid-market and large corporations. We understand the challenges of leveraging funding for product development from dynamic research programs in a competitive environment. We're experienced in US and foreign patent prosecution, patent litigation, post-grant proceedings, opinions related to non-infringement, invalidity, freedom to operate, inventorship disputes, licensing, portfolio analysis, and competitor analysis.

Our patent prosecutors have extensive experience dealing with patent eligibility matters and work with a wide array of technologies including the following:

  • Antibodies
  • Aptamers
  • Aquaculture
  • Biofuels
  • Cancer therapies and vaccines
  • CAR T-cells
  • Cell culture
  • Chromatography systems
  • CRISPR technology
  • Drug delivery vehicles
  • Drug formulation
  • ELISA
  • Fluorescence in situ hybridization
  • Food science and enzymes
  • Gene therapy
  • Genetic adjuvants
  • Genomics
  • Immunotherapeutics
  • Industrial chemical and biochemical processes
  • Medical diagnostics
  • Microscopy technology and image analysis
  • Modular agricultural systems
  • Nanoparticles
  • Nucleic acids
  • Nutritional biochemistry
  • Probes
  • Proteins
  • Sequencing technology
  • Small molecule pharmaceuticals
  • Spectrometry
  • Stem cells
  • Targeting of drugs and biologics
  • Test kits
  • Transgenic animals
  • Treatment of diabetes and metabolic diseases
  • Viral vectors

Examples of how our patent attorneys have helped their biotech clients include:

  • Quickly established a patent portfolio in the competitive CAR T-cell space to support funding efforts of a biotech startup.
  • Assisted an instrumentation company in an inventorship dispute with its research collaborator, resulting in the company establishing its own patent portfolio.
  • Obtained broad patent coverage for a biologics formulations company to support its partnering efforts.

Firm Highlights

Publication/Podcast

EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...

Event

IP & Business Transactional Strategies as Life Science Companies Plan Their U.S. Market Entry

Business law attorney Eugene Ho and IP attorney Beverly Hjorth will be presenting for ACTION Innovation Network members for its webinar series, discussing what life science companies should be thinking about when considering entry...

Matter

Management Audit

Verrill represented Emera in its 2016 distribution rate case before the Maine PUC. The case involved issues relating to significant new capital investments, including Emera's new customer information system and a controversial substation investment...

Event

2020 OHRP Exploratory Workshop

Health care attorney Emily Fogler will be presenting at the 2020 OHRP Exploratory Workshop in the third session, discussing sharing responsibilities and protecting participants - redefining roles in the single IRB era. For more...

Blog

Verrill Helps State’s Largest Solar Project Obtain Principal Environmental Permit

Blog

Verrill Helps State’s Largest Solar Project Obtain Principal Environmental Permit

Publication/Podcast

PPP: How is Maine Faring?

Originally enacted on March 27, the Paycheck Protection Program (PPP) offers loan support and (potentially) loan forgiveness to qualifying small businesses – generally defined as those with not more than 500 employees. According to...

News

Verrill’s Wide-Ranging Private Wealth Law Practice Recognized in 2020 Chambers and Partners High Net Worth Guide

(July 20, 2020) – Verrill attorneys Michael Fay, Kurt Klebe, Mary McQuillen, and Jacqueline Rider were recognized in the Chambers High Net Worth 2020 Guide , Chambers and Partners' fifth edition of the publication...

News

After the EPA Inspector Leaves

On July 17, environmental attorney Mat Todaro appeared on an episode of Amplify Your Process Safety, a process safety and risk management podcast. Co-host Rob Bartlett and Mat discuss EPA inspections, what to expect...

Matter

2017 Emera Distribution Rate Case

Verrill represented Emera in its 2017 distribution rate case before the Maine PUC, which included: defeating Staff's proposed reduction to allowed return on equity for "management inefficiency;" approval of new expenditures, such as an...